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Background
I n f o r m a t i o no nH P Vg e n o t y p e - s p e c i f i ci n c i d e n c ea n d
clearance is important to better inform the natural his-
tory of cervical neoplasia in context of HIV/AIDS. We
conducted a cohort study among HIV-infected women
in Pune, India to estimate the genotype-specific HPV
incidence and clearance rates.
Methods
HIV-infected women underwent baseline and annual
follow-up visits for cervical cancer screening and collec-
tion of cervicovaginal samples for detection of 37 HPV
genotypes by Linear Array polymerase chain reaction
(PCR) assay.
Results
A total of 215 eligible participants were followed for a
median time of 11 months (range: 8-23 months) with a
follow-up period of 223 person-years. Of the 104/215
(48.4 %) HIV-infected women who were HPV-negative
at baseline, 12 women were newly detected with HPV at
follow-up visit reflecting an incidence rate of 5.4 per
100 person-years. Type-specific incidence rates ranged
between 0.45-3.42 per 100 person-years for carcinogenic
HPV types and between 0.45-1.79 per 100 person-years
for other HPV types. Of the 111/215 (51.6 %) women
with HPV at baseline, 21 women cleared all types,
reflecting a clearance rate of 9.4 per 100 person-years.
Type-specific clearance rates ranged between 0.45-4.48
per 100 person-years for carcinogenic HPV types and
between 0.45-4.04 for other HPV types.
Conclusions
This study adds to the scant global data of natural his-
tory of HPV infection in HIV-infected women. Knowl-
edge of incidence and clearance rates can inform cost
effectiveness and decision analysis models for estimating
effectiveness of HPV vaccination and screening strate-
gies for cervical cancer prevention for HIV-infected
women.
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